Literature DB >> 24682898

Ciliary neurotrophic factor reverses aberrant mitochondrial bioenergetics through the JAK/STAT pathway in cultured sensory neurons derived from streptozotocin-induced diabetic rodents.

Subir Roy Chowdhury1, Ali Saleh, Eli Akude, Darrell R Smith, Dwane Morrow, Lori Tessler, Nigel A Calcutt, Paul Fernyhough.   

Abstract

Mitochondrial dysfunction occurs in sensory neurons and contributes to diabetic neuropathy. Ciliary neurotrophic factor (CNTF) stimulates axon regeneration in type 1 diabetic rodents and prevents deficits in axonal caliber, nerve conduction, and thermal sensation. We tested the hypothesis that CNTF enhances sensory neuron function in diabetes through JAK/STAT (Janus kinase/signal transducers and activators of transcription) signaling to normalize impaired mitochondrial bioenergetics. The effect of CNTF on gene expression and neurite outgrowth of cultured adult dorsal root ganglia (DRG) sensory neurons derived from control and streptozotocin (STZ)-induced diabetic rodents was quantified. Polarization status and bioenergetics profile of mitochondria from cultured sensory neurons were determined. CNTF treatment prevented reduced STAT3 phosphorylation (Tyr 705) in DRG of STZ-diabetic mice and also enhanced STAT3 phosphorylation in rat DRG cultures. CNTF normalized polarization status of the mitochondrial inner membrane and corrected the aberrant oligomycin-induced mitochondrial hyperpolarization in axons of diabetic neurons. The mitochondrial bioenergetics profile demonstrated that spare respiratory capacity and respiratory control ratio were significantly depressed in sensory neurons cultured from STZ-diabetic rats and were corrected by acute CNTF treatment. The positive effects of CNTF on neuronal mitochondrial function were significantly inhibited by the specific JAK inhibitor, AG490. Neurite outgrowth of sensory neurons from age-matched control and STZ-induced diabetic rats was elevated by CNTF and blocked by AG490. We propose that CNTF's ability to enhance axon regeneration and protect from fiber degeneration in diabetes is associated with its targeting of mitochondrial function and improvement of cellular bioenergetics, in part, through JAK/STAT signaling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24682898     DOI: 10.1007/s10571-014-0054-9

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  14 in total

Review 1.  Assessing mitochondrial dysfunction in cells.

Authors:  Martin D Brand; David G Nicholls
Journal:  Biochem J       Date:  2011-04-15       Impact factor: 3.857

Review 2.  Overcoming insulin resistance with ciliary neurotrophic factor.

Authors:  Tamara L Allen; Vance B Matthews; Mark A Febbraio
Journal:  Handb Exp Pharmacol       Date:  2011

3.  Ciliary neurotrophic factor activates NF-κB to enhance mitochondrial bioenergetics and prevent neuropathy in sensory neurons of streptozotocin-induced diabetic rodents.

Authors:  Ali Saleh; Subir K Roy Chowdhury; Darrell R Smith; Savitha Balakrishnan; Lori Tessler; Corina Martens; Dwane Morrow; Emily Schartner; Katie E Frizzi; Nigel A Calcutt; Paul Fernyhough
Journal:  Neuropharmacology       Date:  2012-09-26       Impact factor: 5.250

Review 4.  The ciliary neurotrophic factor and its receptor, CNTFR alpha.

Authors:  M W Sleeman; K D Anderson; P D Lambert; G D Yancopoulos; S J Wiegand
Journal:  Pharm Acta Helv       Date:  2000-03

5.  Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor.

Authors:  N A Calcutt; J D Freshwater; A P Mizisin
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

6.  Metabolic remodeling in adipocytes promotes ciliary neurotrophic factor-mediated fat loss in obesity.

Authors:  Seamus Crowe; Sarah M Turpin; Francine Ke; Bruce E Kemp; Matthew J Watt
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

7.  Ciliary neurotrophic factor improves nerve conduction and ameliorates regeneration deficits in diabetic rats.

Authors:  Andrew P Mizisin; Yvonne Vu; Michelle Shuff; Nigel A Calcutt
Journal:  Diabetes       Date:  2004-07       Impact factor: 9.461

8.  Actin-ATP hydrolysis is a major energy drain for neurons.

Authors:  Barbara W Bernstein; James R Bamburg
Journal:  J Neurosci       Date:  2003-01-01       Impact factor: 6.167

9.  Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes.

Authors:  Subir K Roy Chowdhury; Darrell R Smith; Ali Saleh; Jason Schapansky; Alexandra Marquez; Suzanne Gomes; Eli Akude; Dwane Morrow; Nigel A Calcutt; Paul Fernyhough
Journal:  Brain       Date:  2012-05-04       Impact factor: 13.501

10.  gp130 cytokines are positive signals triggering changes in gene expression and axon outgrowth in peripheral neurons following injury.

Authors:  Richard E Zigmond
Journal:  Front Mol Neurosci       Date:  2012-01-20       Impact factor: 5.639

View more
  14 in total

1.  Enhanced Transcriptional Activity and Mitochondrial Localization of STAT3 Co-induce Axon Regrowth in the Adult Central Nervous System.

Authors:  Xueting Luo; Marcio Ribeiro; Eric R Bray; Do-Hun Lee; Benjamin J Yungher; Saloni T Mehta; Kinjal A Thakor; Francisca Diaz; Jae K Lee; Carlos T Moraes; John L Bixby; Vance P Lemmon; Kevin K Park
Journal:  Cell Rep       Date:  2016-03-31       Impact factor: 9.423

Review 2.  Mitochondrial hormesis and diabetic complications.

Authors:  Kumar Sharma
Journal:  Diabetes       Date:  2015-03       Impact factor: 9.461

3.  AAV9-Mediated Cardiac CNTF Overexpression Exacerbated Adverse Cardiac Remodeling in Streptozotocin-Induced Type 1 Diabetic Models.

Authors:  Peng Zhong; Jianye Peng; Tao Liu; Hua-Sheng Ding
Journal:  Cardiovasc Toxicol       Date:  2021-10-21       Impact factor: 3.231

4.  CCDC7 Activates Interleukin-6 and Vascular Endothelial Growth Factor to Promote Proliferation via the JAK-STAT3 Pathway in Cervical Cancer Cells.

Authors:  Xiang He; Chun-Ting Wang; Cong Zhou; Qi Zeng; Peng Zhang
Journal:  Onco Targets Ther       Date:  2020-06-30       Impact factor: 4.147

5.  Amelioration of Both Central and Peripheral Neuropathy in Mouse Models of Type 1 and Type 2 Diabetes by the Neurogenic Molecule NSI-189.

Authors:  Corinne G Jolivalt; Alexandra Marquez; David Quach; Michelle C Navarro Diaz; Carlos Anaya; Betelhem Kifle; Nabeel Muttalib; Gabriela Sanchez; Lucy Guernsey; Mike Hefferan; Darrel R Smith; Paul Fernyhough; Karl Johe; Nigel A Calcutt
Journal:  Diabetes       Date:  2019-09-06       Impact factor: 9.461

6.  Transcriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns.

Authors:  Junguk Hur; Phillipe D O'Brien; Viji Nair; Lucy M Hinder; Brett A McGregor; Hosagrahar V Jagadish; Matthias Kretzler; Frank C Brosius; Eva L Feldman
Journal:  Diabetologia       Date:  2016-03-21       Impact factor: 10.122

Review 7.  Non-glucose risk factors in the pathogenesis of diabetic peripheral neuropathy.

Authors:  Kyung Ae Lee; Tae Sun Park; Heung Yong Jin
Journal:  Endocrine       Date:  2020-09-07       Impact factor: 3.633

8.  Ciliary neurotrophic factor-treated astrocyte-conditioned medium increases the intracellular free calcium concentration in rat cortical neurons.

Authors:  Meiqun Sun; Hongli Liu; Shengping Min; Hongtao Wang; Xiaojing Wang
Journal:  Biomed Rep       Date:  2016-02-17

9.  In vitro neuroprotective effects of ciliary neurotrophic factor on dorsal root ganglion neurons with glutamate-induced neurotoxicity.

Authors:  Shu-Yun Wen; Ai-Min Li; Kuan-Qing Mi; Rui-Zheng Wang; Hao Li; Hua-Xiang Liu; Yi Xing
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

10.  Conserved Transcriptional Signatures in Human and Murine Diabetic Peripheral Neuropathy.

Authors:  Brett A McGregor; Stephanie Eid; Amy E Rumora; Benjamin Murdock; Kai Guo; Guillermo de Anda-Jáuregui; James E Porter; Eva L Feldman; Junguk Hur
Journal:  Sci Rep       Date:  2018-12-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.